Boylan James P
SEC insider (Form 3/4/5 filer). CIK 0001953094. Director at Zenas BioPharma, Inc. (ZBIO) and 3 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in BOTHELL, WA.
Companies Boylan James P has filed insider reports for
- Zenas BioPharma, Inc. (ZBIO): Director
- Immunome Inc. (IMNM): Director
- Compass Therapeutics, Inc. (CMPX): Director
- Camp4 Therapeutics Corp (CAMP): Director
Boylan James P
CIK: 0001953094
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 15, 2026ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
18.5K shares- - Jun 10, 2026IMNM
Immunome Inc.
AwardDirectDirector Stock Option (right to buy)
9.9K shares- - Jan 2, 2026CMPX
Compass Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
90K shares- - Jun 25, 2025CAMP
Camp4 Therapeutics Corp
AwardDirectStock Option (Right to Buy)
9K shares- - Jun 10, 2025IMNM
Immunome Inc.
AwardDirectDirector Stock Option (right to buy)
18.9K shares- - Jun 10, 2025ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
18.5K shares- - Feb 11, 2025CMPX
Compass Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Sep 12, 2024ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
37K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 18,500 | - | - | Direct |
| Jun 10, 2026 |  IMNM Immunome Inc. | Award Director Stock Option (right to buy) | 9,897 | - | - | Direct |
| Jan 2, 2026 |  CMPX Compass Therapeutics, Inc. | Award Stock Option (Right to Buy) | 90,000 | - | - | Direct |
| Jun 25, 2025 |  CAMP Camp4 Therapeutics Corp | Award Stock Option (Right to Buy) | 9,000 | - | - | Direct |
| Jun 10, 2025 | IMNM Immunome Inc. | Award Director Stock Option (right to buy) | 18,864 | - | - | Direct |
| Jun 10, 2025 | ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 18,500 | - | - | Direct |
| Feb 11, 2025 | CMPX Compass Therapeutics, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Sep 12, 2024 | ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 37,000 | - | - | Direct |
1-8 of 8 transactions